International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 2 , Pages 407-421 , 1 June 2002

Relative biological effectiveness (RBE) values for proton beam therapy

  • Harald Paganetti, Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests to: Harald Paganetti, Ph.D., Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114USA. Tel: (617) 726-5847; Fax: (617) 724-1214
    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • ,
  • Andrzej Niemierko, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • ,
  • Marek Ancukiewicz, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • ,
  • Leo E Gerweck, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • ,
  • Michael Goitein, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • ,
  • Jay S Loeffler, M.D.

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • ,
  • Herman D Suit, M.D. (D.Phil.)

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA

Received 13 August 2001 ,Revised 18 January 2002 ,Accepted 28 January 2002.

References 

  1. Wambersie A. RBE, reference RBE, and clinical RBE (Applications of these concepts in hadron therapy). Strahlenther Onkol. 1999;175(Suppl. 2):39–43
  2. Sinclar WK. The relative biological effectiveness of 22-MVp X-rays, cobalt-60 gamma-rays, and 200 kVp X-rays. VII (Summary of studies for five criteria of effect). Radiat Res. 1962;16:394–398
  3. Robertson JB, Williams JR, Schmidt RA, et al.  Radiobiological studies of a high-energy modulated proton beam utilizing cultured mammalian cells. Cancer. 1975;35:1664–1677
  4. Raju MR. Heavy particle radiotherapy. New York: Academic Press; 1980;
  5. Jones B, Dale RG. Estimation of optimum dose per fraction for high LET radiations (Implications for proton radiotherapy). Int J Radiat Oncol Biol Phys. 2000;48:1549–1557
  6. Robertson JB, Eaddy JM, Archambeau JO, et al.  Relative biological effectiveness and microdosimetry of a mixed energy field of protons up to 200 MeV. Adv Space Res. 1994;14:271–275
  7. Paganetti H, Goitein M. Radiobiological significance of beam line dependent proton energy distributions in a spread-out Bragg peak. Med Phys. 2000;27:1119–1126
  8. Skarsgard LD. Radiobiology with heavy charged particles (A historical review). Physica Medica. 1998;14(Suppl. 1):1–34
  9. Newhauser W, Smith A, Burns J, et al.  A report on the change in the proton absorbed dose measurement protocol for the clinical trials conducted at the Harvard Cyclotron Laboratory (abstract). Med Phys. 1998;25:A144–A145
  10. Spadinger I, Palcic B. The relative biological effectiveness of 60Co gamma-rays, 55 kVp X-rays, 250 kVp X-rays, and 11 MeV electrons at low doses. Int J Radiat Biol. 1992;61:345–353
  11. Hall EJ. The relative biological efficiency of X rays generated at 220 kVp and gamma radiation from a Cobalt 60 therapy unit. Br J Radiol. 1961;34:313–317
  12. Hering ER. An investigation of changes in relative biological effectiveness (RBE) with depth for X ray beams generated between 100 and 250 kVp using the mouse foot as biological test system. Int J Radiat Oncol Biol Phys. 1986;12:815–821
  13. Blomquist E, Russell KR, Stenerloew B, et al.  Relative biological effectiveness of intermediate energy protons (Comparisons with 60Co gamma-radiation using two cell lines). Radiother Oncol. 1993;28:44–51
  14. Hall EJ, Kellerer AM, Rossi HH, et al.  The relative biological effectiveness of 160 MeV protons. II. Biological data and their interpretation in terms of microdosimetry. Int J Radiat Oncol Biol Phys. 1978;4:1009–1013
  15. Wouters BG, Lam GKY, Oelfke U, et al.  RBE measurement on the 70 MeV proton beam at TRIUMF using V79 cells and the high precision cell sorter assay. Radiat Res. 1996;146:159–170
  16. Bettega D, Calzolari P, Marchesini R, et al.  Inactivation of C3H10T1/2 cells by low energy protons and deuterons. Int J Radiat Biol. 1998;73:303–309
  17. Belli M, Bettega D, Calzolari P, et al.  Inactivation of human normal and tumour cells irradiated with low energy protons. Int J Radiat Biol. 2000;76:831–839
  18. Coutrakon G, Cortese J, Ghebremedhin A, et al.  Microdosimetry spectra of the Loma Linda proton beam and relative biological effectiveness comparisons. Med Phys. 1997;24:1499–1506
  19. Slabbert JP, Jones DTL, Schreuder N, et al.  Variations in biological effectiveness with depth in a 200 MeV proton beam. In: NAC Annual Report. 1994;p. 103–106
  20. Ando K, Furusawa Y, Suzuki M, et al.  Relative biological effectiveness of the 235 MeV proton beams at the National Cancer Center Hospital East. J Radiat Res. 2001;42:79–89
  21. Bettega D, Calzolari P, Chauvel P, et al.  Radiobiological studies on the 65 MeV therapeutic proton beam at Nice using human tumour cells. Int J Radiat Biol. 2000;76:1297–1303
  22. Tang JT, Inoue T, Inoue T, et al.  Comparison of radiobiological effective depths in 65-MeV modulated proton beams. Br J Cancer. 1997;76:220–225
  23. Gueulette J, Gregoire V, Octave-Prignot M, et al.  Measurements of radiobiological effectiveness in the 85 MeV proton beam produced at the cyclotron CYCLONE of Louvain-la-Neuve, Belgium. Radiat Res. 1996;145:70–74
  24. Yashkin PN, Silin DI, Zolotov VA, et al.  Relative biological effectiveness of proton medical beam at Moscow synchrotron determined by the Chinese hamster cells assay. lnt J Radiat Oncol Biol Phys. 1995;31:535–540
  25. Schettino G, Folkard M, Prise KM, et al.  Low-dose hypersensitivity in Chinese hamster V79 cells targeted with counted protons using a charged-particle microbeam. Radiat Res. 2001;156:526–534
  26. Matsubara S, Ohara H, Hiraoka T, et al.  Chromosome aberration frequencies produced by a 70-MeV proton beam. Radiat Res. 1990;123:182–191
  27. Cherubini R, Cera F, Dalla Vecchia M, et al.  Biological effectiveness of light ions for cell inactivation and mutation induction on V79 cells. In: Fifth Workshop on Heavy Charged Particles in Biology and Medicine. Darmstadt, Germany: Gesellschaft für Schwerionenforschung (GSl); 1995;p. 73–76
  28. Green LM, Murray DK, Tran DT, et al.  Response of thyroid follicular cells to gamma irradiation compared to proton irradiation. I. Initial characterization of DNA damage, micronucleus formation, apoptosis, cell survival, and cell cycle phase redistribution. Radiat Res. 2001;155:32–42
  29. Sgura A, Antoccia A, Cherubini R, et al.  Micronuclei, CREST-positive micronuclei, and cell inactivation induced in Chinese hamster cells by radiation with different quality. Int J Radiat Biol. 2000;76:367–374
  30. Radojcic M, Crompton NEA. Age dependence of T-lymphocyte apoptosis induced by high-energy proton exposure. Radiat Env Biophys. 2001;40:131–135
  31. Tepper J, Verhey L, Goitein M, et al.  In vivo determinations of RBE in a high energy modulated proton beam using normal tissue reactions and fractionated dose schedules. Int J Radiat Oncol Biol Phys. 1977;2:1115–1122
  32. Gueulette J, Boehm L, De Coster B-M, et al.  RBE variation as a function of depth in the 200-MeV proton beam produced at the National Accelerator Centre in Faure (South Africa). Radiother Oncol. 1997;42:303–309
  33. Gueulette J, Slabbert JP, Boehm L, et al.  Proton RBE for early intestinal tolerance in mice after fractionated irradiation. Radiother Oncol. 2001;61:177–184
  34. Nemoto K, Pickles T, Minchinton AI, et al.  The relative biological effectiveness of the modulated proton beam at TRIUMF. Radiat Med. 1998;16:43–46
  35. Tatsuzaki H, Okumura T, Tsuji H, et al.  An RBE study of a proton beam at University of Tsukuba (vs. Co-60). Proceedings of the XXI PTCOG meeting. 1994;146–148 Chiba, Japan, 14–16 Nov.
  36. Gueulette J, Boehm L, Slabbert JP, et al.  Proton relative biological effectiveness (RBE) for survival in mice after thoracic irradiation with fractional doses. Int J Radiat Oncol Biol Phys. 2000;47:1051–1058
  37. Urano M, Verhey LJ, Goitein M, et al.  Relative biological effectiveness of modulated proton beams in various murine tissues. Int J Radiat Oncol Biol Phys. 1984;10:509–514
  38. Urano M, Goitein M, Verhey L, et al.  Relative biological effectiveness of a high energy modulated proton beam using a spontaneous murine tumor in vivo. Int J Radiat Oncol Biol Phys. 1980;6:1187–1193
  39. Ando K, Koike S, Kawachi K, et al.  Relative biological effectiveness of the therapeutic proton beams at NIRS and Tsukuba University (in Japanese). Nippon Igaku Hoshasen Gakkai Zasshi. 1985;45:531–535
  40. Kajioka EH, Andres ML, Li J, et al.  Acute effects of whole-body proton irradiation on the immune system of the mouse. Radiat Res. 2000;153:587–594
  41. Bettega D, Birattari C, Bombana M, et al.  Relative biological effectiveness for protons of energies up to 31 MeV. Radiat Res. 1979;77:85–97
  42. Perris A, Pialoglou P, Katsanos AA, et al.  Biological effectiveness of low energy protons. I. Survival of Chinese hamster cells. Int J Radiat Biol. 1986;50:1093–1101
  43. Folkard M, Prise KM, Vojnovic B, et al.  Inactivation of V79 cells by low-energy protons, deuterons and helium-3 ions. Int J Radiat Biol. 1996;69:729–738
  44. Belli M, Cera F, Cherubini R, et al.  Inactivation and mutation induction in V79 cells by low energy protons (Re-evaluation of the results at the LNL facility). Int J Radiat Biol. 1993;63:331–337
  45. Dellert M, Distel L, Eyrich W, et al.  Biological effectiveness of protons on mammalian cells. In:  Amaldi U,  Larsson B,  Lemoigne Y editor. Advances in Hadrontherapy. Amsterdam: Elsevier Science; 1997;p. 420–426
  46. Folkard M, Prise KM, Vojnovic B, et al.  The irradiation of V79 mammalian cells by protons with energies below 2 MeV. Part I (Experimental arrangement and measurement of cell survival). Int J Radiat Biol. 1989;56:221–237
  47. Courdi A, Brassart N, Herault J, et al.  The depth-dependent radiation response of human melanoma cells exposed to 65 MeV protons. Br J Radiol. 1994;67:800–804
  48. Debus J, Hug EB, Liebsch NJ, et al.  Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys. 1997;39:967–975
  49. Schultheiss TE, Kun LE, Ang KK, et al.  Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys. 1995;31:1093–1112
  50. Emami B, Lyman J, Brown A, et al.  Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  51. Marcus RB, Million RR. The incidence of myelitis after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys. 1990;19:3–8
  52. Benk VA, Adams JA, Shipley WU, et al.  Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. Int J Radiat Oncol Biol Phys. 1993;26:551–557
  53. Skwarchuk MW, Jackson A, Zelefsky MJ, et al.  Late rectal toxicity after conformal radiotherapy of prostate cancer (I) (Multivariate analysis and dose-response). Int J Radiat Oncol Biol Phys. 2000;47:103–113
  54. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol. 1984;23:379–391
  55. Goodhead DT. Radiation effects in living cells. Can J Phys. 1990;68:872–886
  56. Paganetti H. Calculation of the spatial variation of relative biological effectiveness in a therapeutic proton field for eye treatment. Phys Med Biol. 1998;43:2147–2157
  57. Paganetti H, Olko P, Kobus H, et al.  Calculation of RBE for proton beams using biological weighting functions. Int J Radiat Oncol Biol Phys. 1997;37:719–729
  58. Paganetti H, Goitein M. Biophysical modeling of proton radiation effects based on amorphous track models. Int J Radiat Biol. 2001;9:911–928
  59. Seltzer SM. In: An assessment of the role of charged secondaries from nonelastic nuclear interactions by therapy proton beams in water. 5221:Gaithersburg, MD: National Institute of Standards and Technology Report; 1993;p. 1–80
  60. Paganetti H, Schmitz T. The influence of the beam modulation method on dose and RBE in proton radiation therapy. Phys Med Biol. 1996;41:1649–1663
  61. Paganetti H. Nuclear interactions in proton therapy (Dose and relative biological effect distributions originating from primary and secondary particles). Phys Med Biol. 2002;47:747–764
  62. Cucinotta FA, Katz R, Wilson JW, et al.  Biological effectiveness of high-energy protons (Target fragmentation). Radiat Res. 1991;127:130–137
  63. Gerweck L, Kozin SV. Relative biological effectiveness of proton beams in clinical therapy. Radiother Oncol. 1999;50:135–142
  64. Paganetti H, Gerweck LE, Goitein M. The general relation between tissue response to x-radiation (α/β-values) and the relative biological effectiveness (RBE) of protons (Prediction by the Katz track-structure model). Int J Radiat Biol. 2000;76:985–998
  65. Warenius HM, Britten RA, Peacock JH. The relative cellular radiosensitivity of 30 human in vitro cell lines of different histological type to high LET 62.5 MeV (p → Be+) fast neutrons and 4 MeV photons. Radiother Oncol. 1994;30:83–89
  66. Withers HR, Mason K, Reid BO, et al.  Response of mouse intestine to neutrons and gamma rays in relation to dose fractionation and division cycle. Cancer. 1974;34:39–47
  67. Hornsey S. RBE for lung and cord. Int J Radiat Oncol Biol Phys. 1982;8:2099–2102
  68. Wainson AA, Lomanov MF, Shmakova NL, et al.  The RBE of accelerated protons in different parts of the Bragg curve. Br J Radiol. 1972;45:525–529
  69. Satoh S, Inada T, Eguchi K, et al.  Studies on relative biological effectiveness and therapeutic gain factor of high energy protons modulated for radiotherapy (in Japanese). Nippon Igaku Hoshasen Gakkai Zasshi. 1986;46:714–721
  70. Inada T, Kawachi K, Kanai T, et al.  Inactivation of cultured human tumor cells irradiated by cyclotron neutrons and protons. J Radiat Res. 1981;22:143–153
  71. Tatsuzaki H, Inada T, Shimizu T, et al.  Early skin reaction following 250 MeV proton peak irradiation. J Radiat Res. 1987;28:150–155
  72. Tatsuzaki H, Inada T, Arimoto T, et al.  Early and late effects of fractionated 250 MeV proton beam irradiation on murine legs. J Jpn Soc Ther Radiol Oncol. 1991;3:171–179

☆ Supported in part by Grants CA 50628 and CA 21239 from the National Cancer Institute, DHHS.

PII: S0360-3016(02)02754-2

International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 2 , Pages 407-421 , 1 June 2002

Article Tools

* Image Usage & Resolution